So close, yet so far: Zogenix LGS trial succeeds, but results underwhelm
Merely crossing the finish line isn’t enough — the win must be decisive. Ask Zogenix, whose experimental seizure drug met the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
